DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Tumor necrosis factor-induced interleukin-6 expression and cytotoxicity follow a common signal transduction pathway in L929 cells.

Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro.

Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Phospholipase A2 activity is not involved in the tumor necrosis factor-triggered apoptotic DNA fragmentation in bovine aortic endothelial cells.

Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha.

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.

Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.

Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells.

DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.

Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-α fusion protein.

The p70 tumor necrosis factor receptor mediates cytotoxicity.

Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma.

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.

Induction of interleukin 6 production by interleukin 1 and tumor necrosis factor in human hepatoma cells.

Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha.

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line.

Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain.

Suggest Documents

Tumor necrosis factor-induced interleukin-6 expression and cytotoxicity follow a common signal transduction pathway in L929 cells.

Recombinant human tumor necrosis factor-beta entrapped in liposomes formed by a modification of the dehydration-rehydration method retains potent cytotoxic activity on L929 cells in vitro.

Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

Phospholipase A2 activity is not involved in the tumor necrosis factor-triggered apoptotic DNA fragmentation in bovine aortic endothelial cells.

Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha.

Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.

Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.

Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.

Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.

Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells.

DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.

Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-α fusion protein.

The p70 tumor necrosis factor receptor mediates cytotoxicity.

Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma.

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.

Induction of interleukin 6 production by interleukin 1 and tumor necrosis factor in human hepatoma cells.

Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha.

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

In vitro cytotoxicity of human recombinant tumor necrosis factor alpha in association with radiotherapy in a human ovarian carcinoma cell line.

Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain.

DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.

Recommend Documents

Follow Us